1. Academic Validation
  2. Activation of NRF2 blocks HIV replication and apoptosis in macrophages

Activation of NRF2 blocks HIV replication and apoptosis in macrophages

  • Heliyon. 2022 Dec 23;9(1):e12575. doi: 10.1016/j.heliyon.2022.e12575.
Dating Han 1 2 Xiangyun Lu 1 2 Wanpeng Yin 1 2 Haijing Fu 1 2 Xiaodi Zhang 1 2 Linfang Cheng 1 2 Fuming Liu 1 2 Changzhong Jin 1 2 Xuebin Tian 1 2 Yiwen Xie 1 2 Nanping Wu 2 1
Affiliations

Affiliations

  • 1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • 2 Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong, China.
Abstract

Abnormal oxidative stress caused by human immunodeficiency virus (HIV) Infection affects viral replication and causes non-acquired immune deficiency syndrome-related complications in infected individuals. The transcription factor NFE2-related factor 2 (NRF2), a key regulator of oxidative stress, responds to abnormal oxidative stress by regulating the expression of NRF2-dependent cytoprotective genes. The present study aimed to determine whether inhibition of oxidative stress could control HIV replication and improve cell survival. In this study, the NRF2 activator, methyl bardoxolone, was used to treat cells for HIV Infection. The effects on HIV replication and Apoptosis pathways were confirmed by NRF2 activation or knockdown. The results showed that NRF2 activation could block HIV replication in macrophages before the integration phase and inhibited the expression of apoptotic pathways in virus-exposed macrophages. The study presents an unconventional anti-viral strategy of activation antioxidant response for HIV Infection blocking.

Keywords

Apoptosis; HIV; Inflammation; Macrophage; Oxidative stress.

Figures
Products